Cell Robotics signs with Sanwa Kagaku Kenysuho (SKK) for Japan:
This article was originally published in Clinica
Executive Summary
Cell Robotics' Lasette laser finger perforator will be distributed in Japan by Sanwa Kagaku Kenysuho (SKK), a subsidiary of the Suzuken pharmaceutical distribution company. SKK is a leading supplier of diabetic products, with around $250 million sales annually and has 50% of the glucose measuring strip market. SKK will seek Japanese approval for the product. The Lasette is the only FDA-approved laser blood extraction device.
You may also be interested in...
US FDA Expects Joint AdComm Briefing Document, Oncology Chief Says
The combined format is the new default for briefing advisory committee members, US FDA Oncology Center of Excellence Director Pazdur declared.
Parallel Scientific Advice: Is The EMA User Fee Impacting Interest?
EMA charges participants to receive scientific advice through the fledgling program, unlike the US FDA, which may not fit the budgets of some complex generic sponsors. At the same time, sponsors also may simply not be aware the program exists yet.
Medicare-Negotiated Drugs May Not Get Favorable Coverage In Part D: Will CMS Intervene?
Insurance plans put on notice that CMS is concerned about restrictions on drugs with negotiated prices, but it’s not clear what the agency can or will do about it.